🕵️ Envveno Medical Corp ($NVNO)
SEC insider & ownership activity, last 12 months · CIK 1661053 · every row links its SEC filing
Over the last 12 months insiders sold $9K with no open-market buying against it. Duhay Francis sold $9K through a 10b5-1 trading plan in 4 lots (Sep–Jun). One red-flag 8-K in the window: Delisting notice (3.01), Oct 7, 2025.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 1 seller, $9K (4 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Duhay Francis | 0 | – | 4 | $9K | Jun 11, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Perceptive Advisors LLC | 10.0% | 13G | May 15, 2026 | filing ↗ | |
| Joseph Edelman | 10.0% | 13G | May 15, 2026 | filing ↗ | |
| Perceptive Life Sciences Master Fund, Ltd. | 10.0% | 13G | May 15, 2026 | filing ↗ | |
| Thomas A. Satterfield, JR. | 9.0% | 13G | Nov 19, 2025 | filing ↗ | |
| Kingdon Capital Management, L.L.C. | 5.5% | 13G | May 15, 2026 | filing ↗ | |
| M. Kingdon Offshore Master Fund, L.P. | 5.5% | 13G | May 15, 2026 | filing ↗ | |
| Kingdon GP, LLC | 5.5% | 13G | May 15, 2026 | filing ↗ | |
| Mark Kingdon | 5.5% | 13G | May 15, 2026 | filing ↗ | |
| Braeden Lichti | 5.0% | 13D | Feb 20, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Duhay Francis | $1K | Jun 11, 2026 | filing ↗ |
| Duhay Francis | $2K | Mar 12, 2026 | filing ↗ |
| Duhay Francis | $8K | Sep 15, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Reg FD disclosure (7.01) | Jul 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 14, 2026 | filing ↗ |
| Earnings (2.02) | Apr 29, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 29, 2026 | filing ↗ |
| Other events (8.01) | Apr 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 29, 2026 | filing ↗ |
| Earnings (2.02) | Feb 4, 2026 | filing ↗ |
| Other events (8.01) | Feb 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 4, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Jan 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 20, 2026 | filing ↗ |
| Shareholder vote (5.07) | Dec 11, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 11, 2025 | filing ↗ |
| Charter/bylaw changes (5.03) | Nov 17, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 17, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 13, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 13, 2025 | filing ↗ |
| Material agreement (1.01) | Oct 30, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 30, 2025 | filing ↗ |
| Delisting notice (3.01) | Oct 7, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 7, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 20, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 20, 2025 | filing ↗ |